American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults
American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults
BACKGROUND: Central nervous system (CNS) complications are among the most common, devastating sequelae of sickle cell disease (SCD) occurring throughout the lifespan.
OBJECTIVE: These evidence-based guidelines of the American Society of Hematology are intended to support the SCD community in decisions about prevention, diagnosis, and treatment of the most common neurological morbidities in SCD.
METHODS: The Mayo Evidence-Based Practice Research Program supported the guideline development process, including updating or performing systematic evidence reviews. The panel used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, including GRADE evidence-to-decision frameworks, to assess evidence and make recommendations.
RESULTS: The panel placed a higher value on maintaining cognitive function than on being alive with significantly less than baseline cognitive function. The panel developed 19 recommendations with evidence-based strategies to prevent, diagnose, and treat CNS complications of SCD in low-middle- and high-income settings.
CONCLUSIONS: Three of 19 recommendations immediately impact clinical care. These recommendations include: use of transcranial Doppler ultrasound screening and hydroxyurea for primary stroke prevention in children with hemoglobin SS (HbSS) and hemoglobin Sβ0 (HbSβ0) thalassemia living in low-middle-income settings; surveillance for developmental delay, cognitive impairments, and neurodevelopmental disorders in children; and use of magnetic resonance imaging of the brain without sedation to detect silent cerebral infarcts at least once in early-school-age children and once in adults with HbSS or HbSβ0 thalassemia. Individuals with SCD, their family members, and clinicians should become aware of and implement these recommendations to reduce the burden of CNS complications in children and adults with SCD.
1554-1588
DeBaun, M.R.
76559153-80c6-4642-bdf8-672a75570dfe
Jordan, L.C.
1fdccffa-6d8d-47af-a4f8-0a36e632860e
King, A.A.
f9020557-8e1f-448a-ab8d-38db435b6243
Schatz, J.
26f0249d-1156-4c36-9d1b-1d98e408e7b7
Vichinsky, E.
96f0dd63-b632-456f-833d-47e5ffc49360
Fox, C.K.
e1f4cab0-0127-464c-a7d6-2f52a572c345
McKinstry, R.C.
6a775b1a-5925-45a2-8b14-fb108d313208
Telfer, P.
2a7a05d9-a0db-4511-9c82-822f98e3aa12
Kraut, M.A.
68a13f9f-f85b-4e22-83a6-9cd03d0cd2e6
Daraz, L.
bf65a6fb-10d8-443a-aa6e-aad97be30fdd
Kirkham, F.J.
1dfbc0d5-aebe-4439-9fb2-dac6503bcd58
Murad, M.H.
3a23401c-a4bc-49b0-8399-5afd1e42f2cf
28 April 2020
DeBaun, M.R.
76559153-80c6-4642-bdf8-672a75570dfe
Jordan, L.C.
1fdccffa-6d8d-47af-a4f8-0a36e632860e
King, A.A.
f9020557-8e1f-448a-ab8d-38db435b6243
Schatz, J.
26f0249d-1156-4c36-9d1b-1d98e408e7b7
Vichinsky, E.
96f0dd63-b632-456f-833d-47e5ffc49360
Fox, C.K.
e1f4cab0-0127-464c-a7d6-2f52a572c345
McKinstry, R.C.
6a775b1a-5925-45a2-8b14-fb108d313208
Telfer, P.
2a7a05d9-a0db-4511-9c82-822f98e3aa12
Kraut, M.A.
68a13f9f-f85b-4e22-83a6-9cd03d0cd2e6
Daraz, L.
bf65a6fb-10d8-443a-aa6e-aad97be30fdd
Kirkham, F.J.
1dfbc0d5-aebe-4439-9fb2-dac6503bcd58
Murad, M.H.
3a23401c-a4bc-49b0-8399-5afd1e42f2cf
DeBaun, M.R., Jordan, L.C., King, A.A., Schatz, J., Vichinsky, E., Fox, C.K., McKinstry, R.C., Telfer, P., Kraut, M.A., Daraz, L., Kirkham, F.J. and Murad, M.H.
(2020)
American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.
Blood Advances, 4 (8), .
(doi:10.1182/bloodadvances.2019001142).
Abstract
BACKGROUND: Central nervous system (CNS) complications are among the most common, devastating sequelae of sickle cell disease (SCD) occurring throughout the lifespan.
OBJECTIVE: These evidence-based guidelines of the American Society of Hematology are intended to support the SCD community in decisions about prevention, diagnosis, and treatment of the most common neurological morbidities in SCD.
METHODS: The Mayo Evidence-Based Practice Research Program supported the guideline development process, including updating or performing systematic evidence reviews. The panel used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, including GRADE evidence-to-decision frameworks, to assess evidence and make recommendations.
RESULTS: The panel placed a higher value on maintaining cognitive function than on being alive with significantly less than baseline cognitive function. The panel developed 19 recommendations with evidence-based strategies to prevent, diagnose, and treat CNS complications of SCD in low-middle- and high-income settings.
CONCLUSIONS: Three of 19 recommendations immediately impact clinical care. These recommendations include: use of transcranial Doppler ultrasound screening and hydroxyurea for primary stroke prevention in children with hemoglobin SS (HbSS) and hemoglobin Sβ0 (HbSβ0) thalassemia living in low-middle-income settings; surveillance for developmental delay, cognitive impairments, and neurodevelopmental disorders in children; and use of magnetic resonance imaging of the brain without sedation to detect silent cerebral infarcts at least once in early-school-age children and once in adults with HbSS or HbSβ0 thalassemia. Individuals with SCD, their family members, and clinicians should become aware of and implement these recommendations to reduce the burden of CNS complications in children and adults with SCD.
Text
Kirkham_ASHSCDCerebrovascular Manuscript final
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 3 February 2020
e-pub ahead of print date: 16 April 2020
Published date: 28 April 2020
Identifiers
Local EPrints ID: 440622
URI: http://eprints.soton.ac.uk/id/eprint/440622
ISSN: 2473-9529
PURE UUID: d976186a-516a-4769-9040-43add91d534d
Catalogue record
Date deposited: 12 May 2020 16:46
Last modified: 17 Mar 2024 02:53
Export record
Altmetrics
Contributors
Author:
M.R. DeBaun
Author:
L.C. Jordan
Author:
A.A. King
Author:
J. Schatz
Author:
E. Vichinsky
Author:
C.K. Fox
Author:
R.C. McKinstry
Author:
P. Telfer
Author:
M.A. Kraut
Author:
L. Daraz
Author:
M.H. Murad
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics